Results 321 to 330 of about 95,044 (332)
Some of the next articles are maybe not open access.

Idiopathic Pulmonary Fibrosis

Clinics in Chest Medicine, 1982
SUMMARY Idiopathic pulmonary fibrosis is a precise syndrome defined by clinical, roentgenographic, physiologic, and histopathologic features. Clinically, most patients have a nonproductive cough and dyspnea on exertion. The most common physical finding is the presence of crackles over the lower portions of both lungs; also, there may be clubbing ...
openaire   +3 more sources

Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis

Immunology and Allergy Clinics of North America, 2023
Idiopathic pulmonary fibrosis (IPF), a common interstitial lung disease (ILD), is a chronic, progressive fibrosing interstitial pneumonia, with an unknown cause. IPF has been linked to several genetic and environmental risk factors. Disease progression is common and associated with worse outcomes.
Rachel, Strykowski, Ayodeji, Adegunsoye
openaire   +2 more sources

Idiopathic pulmonary fibrosis

Current Opinion in Pulmonary Medicine, 1996
Idiopathic pulmonary fibrosis (IPF), or cryptogenic fibrosing alveolitis as it is known in the United Kingdom and Europe, is perhaps one of the most complex and frustrating pulmonary disorders. The cause of this illness is unknown. Treatment often founders in a mire of discontent, dissatisfaction, and failure. In fact, the philosophic homily "If you do
openaire   +3 more sources

Nintedanib in idiopathic pulmonary fibrosis

Drugs of Today, 2015
Idiopathic pulmonary fibrosis (IPF) conveys a median survival of 3 years and until recently has lacked effective therapies. Nintedanib, an orally available, small-molecule tyrosine kinase inhibitor with selectivity for vascular endothelial growth factor (VEGF), platelet-derived growth factor (PDGF) and fibroblast growth factor (FGF) receptors has ...
Hannah V. Woodcock, Toby M. Maher
openaire   +2 more sources

Idiopathic Pulmonary Fibrosis

Archives of Internal Medicine, 1981
BETSY Harris, MD, Assistant Resident in Medicine, the Jewish Hospital of St Louis: A 49-year-old woman was admitted to the hospital with a five-day history of short-ness of breath. Two weeks before admission, a cough that produced "some whitish material" developed and an oral temperature of 37°C was recorded.
Betsy Harris   +2 more
openaire   +2 more sources

Pulmonary Hypertension in Idiopathic Pulmonary Fibrosis

Chest, 2007
Idiopathic pulmonary fibrosis (IPF) is an untreatable diffuse parenchymal lung disease with a median survival of < 3 years. Pulmonary hypertension (PH) is frequently seen in patients with IPF and is commonly attributed to hypoxic vasoconstriction and capillary destruction. Pathology findings include endothelial proliferation and medial hypertrophy that
David J. Lederer   +3 more
openaire   +3 more sources

Idiopathic pulmonary fibrosis

Meditsinskaya sestra, 2021
Vsevolod V. Skvortsov   +4 more
openaire   +1 more source

Idiopathic Pulmonary Fibrosis

2019
Chronic interstitial lung disease (ILD) is considered a heterogeneous group of pulmonary diseases usually classified on the basis of clinical, radiological and histological aspects, characterized by a variable degree of inflammation and fibrosis. The most diagnosed ILD are idiopathic pulmonary fibrosis (IPF), characterized by the presence of serious ...
Assunta Micco, M. Del Donno, A. Di Sorbo
openaire   +2 more sources

Home - About - Disclaimer - Privacy